Pain specialist participates for the third time in the employee survey and cultural audit of the Great Place to Work® Institute, to reach its self-defined objective of becoming “best employer”.
Aachen (Germany), 4. July, 2013 – At the end of June the Great Place to Work Institute® granted the Grünenthal Group the award of being one of the best employers in Europe. A few weeks before, the pharmaceutical company, specialists in pain research, with headquarters in Aachen, Germany, were pleased to receive the equivalent prize for the Latin American region.
Grünenthal sets itself high standards
According to the results of the employee survey, the employees of the family-owned company are very committed and dedicated in what they do and take a great deal of pride in their company. Especially regarding the working environment, measures to improve employee health and the compatibility of work and family the international company sets high standards and continuously develops its portfolio.
Dr. Heinz-Gerd Suelmann, Executive Vice President Global Human Resources explains Grünenthal’s outstanding commitment and dedication. “We want to provide our employees with a high-class working environment that allows everybody to do an excellent job. We are convinced that being challenged and delivering best performance is a basic human need that brings motivation and therefore pleasure in daily work. To make this happen our colleagues must have the perception of a manageable challenge under the given circumstances and receive recognition and adequate appreciation for their individual performance for the company“.
Grünenthal’s aim is to become the best employer
The annual “Great Place to Work” survey is an important instrument providing neutral feedback for the development of our company culture. The results show where the first milestones have already been reached and where there is still room for development. The Grünenthal affiliates in Spain, Switzerland, Portugal, Italy, the Netherlands, Mexico, Colombia and Peru have already made it on the respective list of the best national employers. For Suelmann receiving this award is a success and obligation at the same time: “Now we have to further expand, maintain and build our unique culture to drive a best practice between all our affiliates to become a great working place worldwide.
The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain treatment, its objective is to become the most patient-centric company and thus to be a leader in therapy innovation.
Grünenthal is one of the last five remaining research-oriented pharmaceutical companies with headquarters in Germany which sustainably invests in research and development. Research and development costs amounted to about 26 percent of revenues in 2012. Grünenthal’s research and development strategy concentrates on selected fields of therapy and state-of-the-art technologies. We are intensely focused on discovering new ways to treat pain better and more effectively, with fewer side-effects than current therapies.
Altogether, the Grünenthal Group has affiliates in 26 countries worldwide. Grünenthal products are sold in more than 155 countries. Today, approx. 4,400 employees are working for the Grünenthal Group worldwide. In 2012, Grünenthal achieved revenues of €973 mn. More information: www.grunenthal.com.
About Great Place to Work®
Great Place to Work® Institute is a global research, consulting and training firm that helps organisations identify, create and sustain great workplaces through the development of high-trust workplace cultures. We serve businesses, non-profits and government agencies, beginning more than 20 years ago with great workplace lists in the United States (with FORTUNE magazine's 100 Best Companies To Work For® list) and Brazil. Today we produce Best Workplaces lists in nearly 50 countries on all continents in what has become the world's largest survey of workplaces, with more than 6000 companies participating.